Jody Vykoukal

Group Leader

The University of Texas MD Anderson Cancer Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Background/Objectives:Cancer vaccine targets mostly include mutations and overexpressed proteins. However, cancer-associated post-translational modifications (PTMs) may also induce immune responses. Previously, our group established the enzyme protein arginine deiminase type-2 (PADI2), which catalyzes citrullination modification, is highly expressed in triple-negative breast cancer (TNBC), promoting antigenicity. Methods: Here, we show the workflow of designing citrullinated enolase 1 (citENO1) vaccine peptides identified from breast cancer cells by mass spectrometry and demonstrate TNBC vaccine efficacy in the mouse model. Immunized mice with citENO1 peptides or the corresponding unmodified peptides, plus Poly I:C as an adjuvant, were orthotopically implanted with a TNBC murine cell line. Results: Vaccination with citENO1, but not unmodified ENO1 (umENO1), induced a greater percentage of activated CD8+ PD-1+ T cells and effector memory T cells in skin-draining lymph nodes (SDLNs). Remarkably, the citENO1 vaccine delayed tumor growth and prolonged overall survival, which was further enhanced by PD-1 blockade. Conclusions: Our data suggest that cancer-restricted post-translational modifications provide a source of vaccines that induce an anti-cancer immune response.

Year:

2025

Supplementary Table S13. Quantification of each protein-specific band normalized to vinculin (macrophage cells (RAW264.7) mono- or cocultured with RM-1-BM EV or SPOPmut models under treatment with OLA, Fig. 5E).

Year:

2025

Supplementary Fig. S19. Heatmaps of common differentially expressed genes in co-cultured and mono-cultured prostate cancer model tumor cells demonstrating significant (FDR

Year:

2025

Supplementary Fig. S21. Double immunofluorescence staining analysis of cleaved caspase 3 and PARP1 in C4-2b-empty vector and C4-2b-SPOPF133V xenograft tumors treated with talazoparib (TALA) or control vehicle

Year:

2025

Supplementary Table S3. Complete listing of antibodies used for immunoblotting (IB) and immunostaining analysis (Fig. 6C, 6D and Extended Data Fig. 5, 6). Vendor and catalog numbers are included in the list.

Year:

2025

Supplementary Table S2. Listing of protein features differentially expressed in Dox-inducible SPOPmut (F102C and F133V) C4-2b prostate cancer cells compared to C4-2b vector control shown in Fig. 2A upper panel

Year:

2025

Purpose: We conducted metabolomics and spatial cell transcriptomics of intraductal papillary mucinous neoplasms (IPMN), recognized pancreatic cancer precursors, to identify oncometabolites that inform upon risk of malignancy of IPMNs. Experimental Design: Untargeted metabolomic analyses were performed on cystic fluid from 125 patients with low-grade (LG) dysplasia or high-grade (HG) dysplasia with/without concurrent pancreatic ductal adenocarcinoma (PDAC; IPMN/PDAC). Predictive performance of individual metabolites for identifying HG or PDAC/IPMN was determined and compared with CA19-9 performance. Data were intersected with metabolic profiles of resected IPMN tissues and murine Kras;Gnas IPMN cell lines as well as spatial and single-cell transcriptomics of IPMNs. Results: A total of 388 metabolites were quantified in cystic fluid, of which 69 were differential ( P -value P -value P -value Conclusions: Cystic fluid polyamines offer utility for determining risk of malignancy of IPMNs that is complementary to CA19-9 and that has potential to aid in clinical management of patients with IPMNs.

Year:

2025

Supplemental Figure S7. Heatmap illustrating differences in gene-based signatures of immune cell types in epilesional (Epi), juxtalesional (Juxta), and perilesional (Peri) regions of high-grade (HG) and IPMN/PDAC compared to low-grade (LG) IPMN.

Year:

2025

Supplemental Figure S4. Scatter plots illustrating associations between cystic fluid spermidine, spermine, diacetylspermidine (DiAcSpmd), and acetylcadaverine (AcCad) [y-axis] and CA19-9 [x-axis].

Year:

2025

Supplementary Fig. S21. Double immunofluorescence staining analysis of cleaved caspase 3 and PARP1 in C4-2b-empty vector and C4-2b-SPOPF133V xenograft tumors treated with talazoparib (TALA) or control vehicle

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (17)

Jianjun Zhang

Professor

Indiana University Richard M Fairbanks School of Public Health

UNITED STATES
View details

Hiroyuki Katayama

Research Group Leader

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Christian Maximillian Schmidt

Professor of Surgery

Indiana University School of Medicine

UNITED STATES
View details

Timothy C. Thompson

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Johannes Fahrmann

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ehsan Irajizad

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Riccardo Ballarò

Senior Research Scientist

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Massimo Loda

Chair

Weill Cornell Medical College

UNITED STATES
View details

Samir M. Hanash

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Paul Corn

Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Eduardo Vilar

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Rachelle Spencer

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

yihui chen

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Michele Yip-Schneider

Senior Research Professor

Indiana University School of Medicine

UNITED STATES
View details

Kim‐Anh Do

-

UNITED STATES
View details

Anirban Maitra

Laura and Isaac Perlmutter Professor of Pathology

NYU Langone Health

UNITED STATES
View details

Timothy Yap

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details